These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22743730)

  • 21. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective.
    Sarasin FP; Majno PE; Llovet JM; Bruix J; Mentha G; Hadengue A
    Hepatology; 2001 May; 33(5):1073-9. PubMed ID: 11343234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repeated-measures implication of hepatocellular carcinoma biomarkers in living donor liver transplantation.
    Chiu KW; Nakano T; Chen KD; Hsu LW; Lai CY; Huang CY; Cheng YF; Goto S; Chen CL
    PLoS One; 2015; 10(5):e0124943. PubMed ID: 25978323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
    Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
    Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
    Sasaki K; Natsugoe S; Aridome K; Ishigami S; Hokita S; Aikou T
    Hepatogastroenterology; 2007 Dec; 54(80):2421-4. PubMed ID: 18265679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal submucosal invasive gastric adenosquamous carcinoma detected at surveillance after gastric endoscopic submucosal dissection.
    Shirahige A; Suzuki H; Oda I; Sekiguchi M; Mori G; Abe S; Nonaka S; Yoshinaga S; Sekine S; Kushima R; Saito Y; Fukagawa T; Katai H
    World J Gastroenterol; 2015 Apr; 21(14):4385-90. PubMed ID: 25892891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
    Lei J; Yan L; Wang W
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Kim JM; Kwon CHD; Joh JW; Han S; Yoo J; Kim K; Sinn DH; Choi GS; Gerber DA; Egawa H; Lee SK
    Transplantation; 2018 Oct; 102(10):1695-1701. PubMed ID: 29494419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
    Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
    Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological features of early gastric cancer: results of 100 cases from a rural general hospital.
    Tachibana M; Takemoto Y; Monden N; Nakashima Y; Kinugasa S; Dhar DK; Kotoh T; Kubota H; Kohno H; Nagasue N
    Eur J Surg; 1999 Apr; 165(4):319-25. PubMed ID: 10365832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report.
    Malagó M; Sotiropoulos GC; Nadalin S; Valentin-Gamazo C; Paul A; Lang H; Radtke A; Saner F; Molmenti E; Beckebaum S; Gerken G; Frilling A; Broelsch CE
    Liver Transpl; 2006 Jun; 12(6):934-40. PubMed ID: 16528715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma.
    Takada Y; Ueda M; Ito T; Sakamoto S; Haga H; Maetani Y; Ogawa K; Kasahara M; Oike F; Egawa H; Tanaka K
    Liver Transpl; 2006 Jun; 12(6):912-9. PubMed ID: 16489583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
    Kim SH; Lee EC; Na BG; Park SJ
    Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early gastric cancer: a single-institution experience on 60 cases.
    Sigon R; Canzonieri V; Rossi C
    Suppl Tumori; 2003; 2(5):S23-6. PubMed ID: 12914385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of perforated advanced gastric carcinoma accompanied with single liver metastases, who underwent total gastrectomy and hepatectomy of caudate lobe after drainage operation of peritonitis].
    Fujisaki S; Takashina M; Tomita R; Sakurai K; Takayama T
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2448-50. PubMed ID: 21224602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.
    Guo L; Orrego M; Rodriguez-Luna H; Balan V; Byrne T; Chopra K; Douglas DD; Harrison E; Moss A; Reddy KS; Williams JW; Rakela J; Mulligan D; Vargas HE
    Liver Transpl; 2006 Apr; 12(4):560-5. PubMed ID: 16555313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation for hepatocellular carcinoma: Korean experience.
    Lee S; Ahn C; Ha T; Moon D; Choi K; Song G; Chung D; Park G; Yu Y; Choi N; Kim K; Kim K; Hwang S
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):539-47. PubMed ID: 19727542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.